These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 23626585)
41. The melanin-concentrating hormone system as a target for the treatment of sleep disorders. Potter LE; Burgess CR Front Neurosci; 2022; 16():952275. PubMed ID: 36177357 [TBL] [Abstract][Full Text] [Related]
42. Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Smith DG; Davis RJ; Rorick-Kehn L; Morin M; Witkin JM; McKinzie DL; Nomikos GG; Gehlert DR Neuropsychopharmacology; 2006 Jun; 31(6):1135-45. PubMed ID: 16205780 [TBL] [Abstract][Full Text] [Related]
43. Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity. Rivera G; Bocanegra-García V; Galiano S; Cirauqui N; Ceras J; Pérez S; Aldana I; Monge A Curr Med Chem; 2008; 15(10):1025-43. PubMed ID: 18393860 [TBL] [Abstract][Full Text] [Related]
46. The role of melanin-concentrating hormone in energy homeostasis and mood disorders. Antal-Zimanyi I; Khawaja X J Mol Neurosci; 2009 Sep; 39(1-2):86-98. PubMed ID: 19418262 [TBL] [Abstract][Full Text] [Related]
47. Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats. Della-Zuana O; Presse F; Ortola C; Duhault J; Nahon JL; Levens N Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1289-95. PubMed ID: 12355323 [TBL] [Abstract][Full Text] [Related]
48. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Marsh DJ; Weingarth DT; Novi DE; Chen HY; Trumbauer ME; Chen AS; Guan XM; Jiang MM; Feng Y; Camacho RE; Shen Z; Frazier EG; Yu H; Metzger JM; Kuca SJ; Shearman LP; Gopal-Truter S; MacNeil DJ; Strack AM; MacIntyre DE; Van der Ploeg LH; Qian S Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3240-5. PubMed ID: 11867747 [TBL] [Abstract][Full Text] [Related]
49. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists. Luthin DR Life Sci; 2007 Jul; 81(6):423-40. PubMed ID: 17655875 [TBL] [Abstract][Full Text] [Related]
55. Estradiol-induced anorexia is independent of leptin and melanin-concentrating hormone. Tritos NA; Segal-Lieberman G; Vezeridis PS; Maratos-Flier E Obes Res; 2004 Apr; 12(4):716-24. PubMed ID: 15090642 [TBL] [Abstract][Full Text] [Related]
56. Characterization of a neuronal cell line expressing native human melanin-concentrating hormone receptor 1 (MCHR1). Fry D; Dayton B; Brodjian S; Ogiela C; Sidorowicz H; Frost LJ; McNally T; Reilly RM; Collins CA Int J Biochem Cell Biol; 2006; 38(8):1290-9. PubMed ID: 16524757 [TBL] [Abstract][Full Text] [Related]
57. Interactions of neuropeptide Y, hypocretin-I (orexin A) and melanin-concentrating hormone on feeding in rats. Sahu A Brain Res; 2002 Jul; 944(1-2):232-8. PubMed ID: 12106685 [TBL] [Abstract][Full Text] [Related]
58. Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice. Kokkotou E; Espinoza DO; Torres D; Karagiannides I; Kosteletos S; Savidge T; O'Brien M; Pothoulakis C Gut; 2009 Jan; 58(1):34-40. PubMed ID: 18824554 [TBL] [Abstract][Full Text] [Related]
59. Recent patents on novel MCH1 receptor antagonists as potential anti-obesity drugs. Szalai KK; Beke G; Éles J; Kitka T; Kovács P; Nagy J; Farkas S; Boros A Recent Pat CNS Drug Discov; 2014; 9(2):122-40. PubMed ID: 24924101 [TBL] [Abstract][Full Text] [Related]